These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4208166)

  • 1. Analysis of spore and antibiotic markers in revertants from asporogenous and sporogenous non-producer mutants of Bacillus subtilis.
    Ray B; Bose SK
    Acta Microbiol Pol A; 1974; 6(1):101-9. PubMed ID: 4208166
    [No Abstract]   [Full Text] [Related]  

  • 2. Exoprotease production by sporogenous and asporogenous mycobacillin non-producer mutants of Bacillus subtilis.
    Bose R; Ray B; Bose SK
    Folia Microbiol (Praha); 1979; 24(5):373-5. PubMed ID: 118901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anabolic and catabolic routes of arginine metabolism in B. subtilis producing bacitracin.
    Paśś L; Styczyńska D; Raczyńska-Bojanowska K
    Acta Biochim Pol; 1974; 21(2):213-24. PubMed ID: 4211804
    [No Abstract]   [Full Text] [Related]  

  • 4. Physiology of spores of mycobacillin producer and non-producer mutants of Bacillus sbutilis.
    Ray B; Bose SK
    Folia Microbiol (Praha); 1974; 19(3):203-8. PubMed ID: 4211149
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mutants of Bacillus subtilis--producer of alkaline proteinase, sporulating in the presence of high concentrations of glucose].
    Dobrzhanskaia EO; Erokhina LI
    Genetika; 1976; 12(7):74-9. PubMed ID: 826455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporulation in Bacillus subtilis. Characterization of oligosporogenous mutants and comparison of their phenotypes with those of asporogenous mutants.
    Coote JG
    J Gen Microbiol; 1972 Jun; 71(1):1-15. PubMed ID: 4625072
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on lipopeptide biosynthesis by Bacillus subtilis: isolation and characterization of iturin-, surfactin+ mutants.
    Feignier C; Besson F; Michel G
    FEMS Microbiol Lett; 1995 Mar; 127(1-2):11-5. PubMed ID: 7737471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second stage production of iturin A by induced germination of Bacillus subtilis RB14.
    Rahman MS; Ano T; Shoda M
    J Biotechnol; 2006 Oct; 125(4):513-5. PubMed ID: 16626834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolation and characteristics of radioresistant Bacillus subtilis and Bacillus thuringiensis mutants].
    Kalinin VL; Petrov VN; Petrovat TM
    Radiobiologiia; 1981; 21(5):676-82. PubMed ID: 6796992
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced iturin A production by Bacillus subtilis and its effect on suppression of the plant pathogen Rhizoctonia solani.
    Mizumoto S; Hirai M; Shoda M
    Appl Microbiol Biotechnol; 2007 Jul; 75(6):1267-74. PubMed ID: 17453193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electron microscopic study of Bacillus subtilis mutants differing in the serine proteinase activity and spectrum].
    Smirnov TA; Ermakova LM; Makar'eva ED; Minenkova IB; Strongin AIa
    Mikrobiologiia; 1978; 47(4):717-21. PubMed ID: 100670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on bacillomycin D biosynthesis by Bacillus subtilis.
    Tenoux I; Besson F; Michel G
    Microbios; 1993; 74(298):29-37. PubMed ID: 8336553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the antifungal antibiotics: bacillomycin D and bacillomycin D methylester.
    Tenoux I; Besson F; Michel G
    Microbios; 1991; 67(272-273):187-93. PubMed ID: 1779878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asporogenous mutants of Bacillus subtilis Marburg.
    Schaeffer P
    Folia Microbiol (Praha); 1967; 12(3):291-6. PubMed ID: 4964470
    [No Abstract]   [Full Text] [Related]  

  • 15. Production of peptide antifungal antibiotic and biocontrol activity of Bacillus subtilis.
    Kumar A; Saini P; Shrivastava JN
    Indian J Exp Biol; 2009 Jan; 47(1):57-62. PubMed ID: 19317353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of divalent ions on the solubility of iturin and bacillomycin L, antifungal peptidolipids of Bacillus subtilis.
    Besson F; Michel G
    Microbios; 1991; 65(262):15-21. PubMed ID: 1901618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative characteristics of spore-forming and asporogenic strains of Bacillus thuringiensis].
    Azizbekian RR; Belykh RA; Netyksa EM; Pogosbekova MR
    Genetika; 1978 Mar; 14(3):510-8. PubMed ID: 640382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacillus subtilis extracellular nuclease production associated with the spoOH sporulation locus.
    Burke WF
    J Gen Microbiol; 1982 Jul; 128(7):1591-7. PubMed ID: 6288842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spores of Bacillus subtilis: their resistance to and killing by radiation, heat and chemicals.
    Setlow P
    J Appl Microbiol; 2006 Sep; 101(3):514-25. PubMed ID: 16907802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid transformation in Bacillus subtilis NB22, an antifungal-antibiotic iturin producer.
    Matsuno Y; Hiraoka H; Ano T; Shoda M
    FEMS Microbiol Lett; 1990 Jan; 55(1-2):227-9. PubMed ID: 2109723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.